GlassScriptSupartz Fx Sodium Hyaluronate
Payments companies reported to CMS as associated with Supartz Fx Sodium Hyaluronate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Supartz Fx Sodium Hyaluronate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Supartz Fx Sodium Hyaluronate
These are the largest totals companies reported as associated with Supartz Fx Sodium Hyaluronate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joshua Carlison | Weyers Cave, VA | Family | $173.18 |
| Mohammed Hadi | Levittown, NY | Pain Medicine (Physical Medicine & Rehabilitation) | $170.34 |
| Richard Fuller | Brookfield, WI | Adult Medicine | $160.18 |
| Tram Tran | Bronx, NY | Physician Assistant | $150.20 |
| May Gresko | Honolulu, HI | Family | $130.86 |
| Chin Kim | Anaheim, CA | Neuromusculoskeletal Medicine, Sports Medicine | $125.83 |
| Louis Gutierrez | San Antonio, TX | Family Medicine | $114.56 |
| Darryl Kan | Honolulu, HI | Sports Medicine (Orthopaedic Surgery) | $106.32 |
| Robert Audet | Weyers Cave, VA | Interventional Pain Medicine | $104.10 |
| Leah Saporita | West Palm Beach, FL | Surgical | $102.94 |
Prescribed Supartz Fx Sodium Hyaluronate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.